-
ICD-10-CM Codes
›
-
E00-E89
›
-
E70-E88
›
-
E70-
›
-
2023 ICD-10-CM Diagnosis Code E70.20
2023 ICD-10-CM Diagnosis Code E70.20
Disorder of tyrosine metabolism, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- E70.20 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM E70.20 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E70.20 - other international versions of ICD-10 E70.20 may differ.
The following code(s) above
E70.20 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
E70.20:
- E00-E89
2023 ICD-10-CM Range E00-E89
Endocrine, nutritional and metabolic diseasesNote- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Type 1 Excludes- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
- E70-E88
2023 ICD-10-CM Range E70-E88
Metabolic disordersType 1 Excludes- androgen insensitivity syndrome (E34.5-)
- congenital adrenal hyperplasia (E25.0)
- hemolytic anemias attributable to enzyme disorders (D55.-)
- Marfan's syndrome (Q87.4)
- 5-alpha-reductase deficiency (E29.1)
Type 2 Excludes- Ehlers-Danlos syndromes (Q79.6-)
- E70.2
ICD-10-CM Diagnosis Code E70.2
Disorders of tyrosine metabolism
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- transitory tyrosinemia of newborn (P74.5)
- Disorder of tyrosine metabolism
- Tyrosine metabolism disorder
ICD-10-CM E70.20 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 642 Inborn and other disorders of metabolism
Convert E70.20 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- Disorder (of) - see also Disease
- metabolism NOS E88.9
ICD-10-CM Diagnosis Code E88.9
Metabolic disorder, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- amino-acid E72.9
ICD-10-CM Diagnosis Code E72.9
Disorder of amino-acid metabolism, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- aromatic E70.9
ICD-10-CM Diagnosis Code E70.9
Disorder of aromatic amino-acid metabolism, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- Disturbance(s) - see also Disease
- metabolism E88.9
ICD-10-CM Diagnosis Code E88.9
Metabolic disorder, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
ICD-10-CM Codes Adjacent To E70.20
E67.2 Megavitamin-B6 syndrome
E67.8 Other specified hyperalimentation
E68 Sequelae of hyperalimentation
E70 Disorders of aromatic amino-acid metabolism
E70.0 Classical phenylketonuria
E70.1 Other hyperphenylalaninemias
E70.2 Disorders of tyrosine metabolism
E70.20
Disorder of tyrosine metabolism, unspecified
E70.29 Other disorders of tyrosine metabolism
E70.311 Autosomal recessive ocular albinism
E70.32 Oculocutaneous albinism
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
